We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

2 hedge funds and large institutions have $69K invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1512 (-149)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 148

100% less funds holding in top 10

Funds holding in top 10: 140 (-14)

100% less capital invested

Capital invested by funds: $2.42B → $69K (-$2.42B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-149
Holders Change %
-98.68%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
1
Closed
148
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
26
Nine Masts Capital
Hong Kong
-$22.7M -525,985 Closed
Morgan Stanley
27
Morgan Stanley
New York
-$21.1M -488,642 Closed
ACPU
28
Arrowgrass Capital Partners (US)
Delaware
-$20.4M -472,151 Closed
TWI
29
Thomas White International
Illinois
-$18.6M -430,986 Closed
BlackRock
30
BlackRock
New York
-$18.5M -427,489 Closed
OAM
31
Oxford Asset Management
United Kingdom
-$17.3M -400,000 Closed
GPGA
32
Grandeur Peak Global Advisors
Utah
-$17.1M -396,743 Closed
RFC
33
Russell Frank Company
Washington
-$16.6M -385,077 Closed
Invesco
34
Invesco
Georgia
-$16.5M -383,000 Closed
BAMCO Inc
35
BAMCO Inc
New York
-$14.8M -341,500 Closed
PCM
36
Pentwater Capital Management
Florida
-$13M -300,000 Closed
GAM
37
Greenwoods Asset Management
Cayman Islands
-$12.8M -296,885 Closed
PPA
38
Parametric Portfolio Associates
Washington
-$11.3M -260,502 Closed
GGHC
39
Gilder Gagnon Howe & Co
New York
-$11.1M -256,101 Closed
Two Sigma Advisers
40
Two Sigma Advisers
New York
-$11M -254,100 Closed
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
-$10.3M -238,914 Closed
Acadian Asset Management
42
Acadian Asset Management
Massachusetts
-$10.2M -235,752 Closed
SAM
43
Silphium Asset Management
United Kingdom
-$9.76M -225,779 Closed
FIG
44
Fortress Investment Group
New York
-$9.56M -221,200 Closed
PAAMCP
45
Pacific Alternative Asset Management Company (PAAMCO)
California
-$9.51M -220,131 Closed
Alyeska Investment Group
46
Alyeska Investment Group
Illinois
-$9.41M -217,771 Closed
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
-$8.79M -203,472 Closed
RSCM
48
Rock Springs Capital Management
Maryland
-$7.56M -175,000 Closed
PAM
49
PSquared Asset Management
Switzerland
-$7.41M -171,495 Closed
California Public Employees Retirement System
50
California Public Employees Retirement System
California
-$7.31M -169,100 Closed

WX Hedge Fund Activity: Q4 2015 in Review

2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2015, worth a combined $69K — down 100% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 148 funds closed out of WX and 1 opened new positions — a net loss of 147 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Crosspoint Capital Strategies, opening a new position worth an estimated $2.83K. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $273M sold.

  • 2 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2015, down from 151 in Q3 2015.
  • Funds reported $69K of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2015, down 100% quarter-over-quarter.
  • 1 fund opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2015 and 148 closed out, a net change of -147 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2015 was Crosspoint Capital Strategies, an estimated $2.83K added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2015 was Schroder Investment Management Group, an estimated $273M sold.

Based on aggregated 13F filings for Q4 2015.